News
US FDA's senior officials express importance of plant biotechnology consultation program
The FDA’s voluntary premarket Plant Biotechnology Consultation Program provides developers the opportunity to engage with the FDA to help navigate the appropriate regulatory pathways in plant-based products to market.
Collaboration aims to reduce racial and ethnic disparities in clinical trials: Henry Ford Health System findings
In-depth interviews were conducted with leaders from U.S. cancer centers with above average recruitment of racial and ethnic minority groups into clinical trials, with the goal of identifying specific strategies that were used to facilitate participation among racial and ethnic minorities.
BioEconomy Conclave 2026
